Tokyo, Japan

Mitsuo Yano


Average Co-Inventor Count = 6.7

ph-index = 7

Forward Citations = 154(Granted Patents)


Location History:

  • Yokohama, JP (1984 - 1994)
  • Tsukuba, JP (1995 - 1996)
  • Tokyo, JP (1992 - 1998)

Company Filing History:


Years Active: 1984-1998

Loading Chart...
13 patents (USPTO):

Title: The Innovations of Mitsuo Yano: A Pharmacological Pioneer

Introduction: Mitsuo Yano, a prominent inventor based in Tokyo, Japan, has made significant contributions to the field of pharmaceuticals with a total of 13 patents to his name. His groundbreaking work, particularly in the realm of endothelin antagonists, showcases his dedication to advancing medical science and addressing critical health issues.

Latest Patents: Among his latest patents, Mitsuo Yano has developed compounds including "Endothelin antagonistic heteroaromatic ring-fused cyclopentene" and "Endothelin antagonistic peptide derivatives." These inventions relate to compounds that act as antagonists of endothelin, presenting processes for their preparation and potential uses as pharmaceuticals. The compounds are particularly useful in treating conditions such as hypertension, pulmonary hypertension, Raynaud's disease, myocardial infarction, angina pectoris, acute renal failure, cerebral infarction, cerebral vasospasm, arteriosclerosis, asthma, endotoxin shock, and more.

Career Highlights: Yano's career at Banyu Pharmaceutical Co. Ltd. marks a significant chapter in his life as he collaborates with a talented team focused on enhancing pharmacological treatments. His 13 patents reflect his innovative approach and commitment to addressing complex medical challenges.

Collaborations: Throughout his career, Mitsuo Yano has worked alongside esteemed colleagues such as Kiyofumi Ishikawa and Takashi Hayama. Together, they have contributed to various advancements in therapeutic treatments, further enriching the field of pharmaceuticals.

Conclusion: Mitsuo Yano's innovative spirit and dedication to research have made him a valued inventor in the pharmaceutical industry. His contributions, especially in the development of endothelin antagonistic compounds, highlight the importance of innovation in medical science, paving the way for new treatments that could transform patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…